Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India

  • Nitesh Gupta | niteshgupta2107@gmail.com Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi, India.
  • Pranav Ish Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi, India. https://orcid.org/0000-0003-1701-4970
  • Rohit Kumar Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi, India.
  • Nishanth Dev Department of Medicine, Safdarjung Hospital, New Delhi, India. https://orcid.org/0000-0003-2486-6725
  • Siddharth Raj Yadav Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi, India.
  • Nipun Malhotra Department of Pulmonary Medicine, Safdarjung Hospital, New Delhi, India. https://orcid.org/0000-0001-7896-5927
  • Sumita Agrawal Department of Pulmonary Medicine, Medipulse Hospital, Jodhpur, India.
  • Rajni Gaind Department of Microbiology, Safdarjung Hospital, New Delhi, India.
  • Harish Sachdeva Department of Anaesthesiology, Safdarjung Hospital, New Delhi, India.
  • *Other members of the Safdarjung Hospital COVID 2019 working group

Abstract

COVID-19 is a pandemic with over 5 million cases worldwide. The disease has imposed a huge burden on health resources. Evaluation of clinical and epidemiological profiles of such patients can help in understanding and managing the outbreak more efficiently. This study was a prospective observational analysis of 200 diagnosed COVID-19 patients admitted to a tertiary care center from 20th march to 8th May 2020. All these patients were positive for COVID-19 by an oro-nasopharyngeal swab-rtPCR based testing. Analyses of demographic factors, clinical characteristics, comorbidities, laboratory parameters, and the outcomes were performed. The mean age of the population was 40 years with a slight male predominance (116 patients out of 200, 58%). A majority of the patients (147, 73.5 %) were symptomatic, with fever being the most common symptom (109, 54.5%), followed by cough (91, 45.5%). An older age, presence of symptoms and their duration, leukocytosis, a high quick SOFA score, a high modified SOFA score, need for ventilator support, an AST level more than 3 times the upper limit of normal (ULN), and a serum creatinine level of 2 mg/dl or greater were at a significantly higher risk of ICU admission and mortality. Presence of diabetes mellitus, AST > three times ULN, serum creatinine 2 mg/dl or higher, and a qSOFA score of 1 or higher were all associated with significantly greater odds of critical care requirement. Triage and severity assessment helps in deciding the requirement for a hospital stay and ICU admission for COVID-19 which can easily be done using clinical and laboratory parameters. A mild, moderate and severe category approach with defined criteria and treatment guidelines will help in judicious utilization of health-care resources, especially for developing countries like India.

 

*Other members of the Safdarjung Hospital COVID-19 working group: Balvinder Singh (Microbiology), MK Sen (Pulmonary Medicine), Shibdas Chakrabarti (Pulmonary Medicine), NK Gupta (Pulmonary medicine), AJ Mahendran (Pulmonary Medicine), Ramesh Meena (Medicine), G Usha (Anaesthesiology), Santvana Kohli (Anaesthesiology), Sahil Diwan (Anaesthesiology), Rushika Saksena (Microbiology), Vikramjeet Dutta (Microbiology), Anupam Kr Anveshi (Microbiology) 

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2020-11-09
Info
Issue
Section
COVID-19 - Collection of articles on the Coronavirus outbreak
Keywords:
COVID-19, SARS-CoV-2, epidemiology, organ dysfunction scores, treatment outcome, prognosis
Statistics
  • Abstract views: 139

  • PDF: 98
How to Cite
Gupta, N., Ish, P., Kumar, R., Dev, N., Yadav, S. R., Malhotra, N., Agrawal, S., Gaind, R., Sachdeva, H., & COVID 2019 working group *Other members of the S. H. (2020). Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India. Monaldi Archives for Chest Disease, 90(4). https://doi.org/10.4081/monaldi.2020.1507

Most read articles by the same author(s)